Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.

Kazia Therapeutics Ltd

KZIA
0,8023
0,0123 (1,56%)
Dopo l'orario di negoziazione
Ultimo aggiornamento: 00:43:18
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Ricevuta di Deposito
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
21/2/202512:33EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
20/2/202522:55EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
20/2/202522:53EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
20/2/202522:51EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
20/2/202514:46PRNUSKazia Therapeutics and the Hebrew University of Jerusalem..
06/2/202506:15EDGAR2Form EFFECT - Notice of Effectiveness
05/2/202522:39EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
03/2/202514:36EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
30/1/202522:31EDGAR2Form F-1 - Registration statement for certain foreign..
30/1/202514:05EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
30/1/202514:02EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
30/1/202513:57EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
30/1/202513:30PRNUSKazia Therapeutics announces the launch of a groundbreaking..
16/1/202516:40EDGAR2Form SCHEDULE 13G - Statement of Beneficial Ownership by..
14/1/202522:00PRNUSKazia Therapeutics Announces Closing of $2.0 Million..
13/1/202514:07EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
13/1/202514:05EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
13/1/202514:03EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
13/1/202514:00EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
10/1/202515:58PRNUSKazia Therapeutics Announces $2.0 Million Registered Direct..
31/12/202414:49EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
31/12/202414:46EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
31/12/202414:43EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
31/12/202414:00PRNUSKazia Therapeutics Provides Update on Paxalisib Regulatory..
11/12/202414:58EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/12/202414:00PRNUSKazia Therapeutics to Present Data Highlighting Synergistic..
03/12/202422:38EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
03/12/202422:33EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
27/11/202422:30EDGAR2Form POS AM - Post-Effective amendments for registration..
27/11/202422:30EDGAR2Form POS AM - Post-Effective amendments for registration..
15/11/202422:02EDGAR2Form 20-F - Annual and transition report of foreign private..
14/11/202422:19EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
12/11/202414:12EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
07/11/202401:53EDGAR2Form SC 13G - Statement of Beneficial Ownership by Certain..
04/11/202422:33EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
04/11/202413:30PRNUSKazia Therapeutics Announces Granting of Type C Meeting with..
01/11/202421:05EDGAR2Form NT 20-F - Notification of inability to timely file Form..
24/10/202414:38EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
24/10/202414:33EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
24/10/202414:28EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
24/10/202414:22EDGAR2Form 6-K/A - Report of foreign issuer [Rules 13a-16 and..
15/10/202413:06EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
15/10/202413:04EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
15/10/202413:03EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
15/10/202413:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
02/10/202422:57EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
02/10/202422:55EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
02/10/202422:52EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
02/10/202422:48EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
02/10/202414:45PRNUSKazia Therapeutics Announces Presentation of Promising Phase..
Apertura: 0,79 Min: 0,79 Max: 0,85
Chiusura: 0,79

La tua Cronologia

Delayed Upgrade Clock

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network